2170307-25-0 Usage
Uses
Used in Biochemical Research:
C51H75N7O30 is used as a research molecule for studying its biological functions and interactions with other molecules in living organisms. Its complex structure and the presence of various functional groups make it a promising candidate for investigating its role in biological processes.
Used in Pharmaceutical Development:
C51H75N7O30 is used as a potential drug candidate for the development of new therapeutic agents. Its unique molecular structure and functional groups may offer novel mechanisms of action and therapeutic benefits in the treatment of various diseases.
Used in Diagnostic Applications:
C51H75N7O30 is used as a diagnostic marker or probe in medical diagnostics. Its specific interactions with biological targets or its unique properties may allow for the detection and monitoring of certain conditions or diseases.
Used in Material Science:
C51H75N7O30 is used as a component in the development of advanced materials with specific properties, such as biocompatibility, biodegradability, or unique mechanical characteristics. Its complex structure and functional groups may contribute to the creation of innovative materials for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 2170307-25-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 2,1,7,0,3,0 and 7 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2170307-25:
(9*2)+(8*1)+(7*7)+(6*0)+(5*3)+(4*0)+(3*7)+(2*2)+(1*5)=120
120 % 10 = 0
So 2170307-25-0 is a valid CAS Registry Number.
2170307-25-0Relevant academic research and scientific papers
SUGAR COMPOUND, METHOD FOR PRODUCING SUGAR COMPOUND, COMPOSITION FOR ENGASE ACTIVITY DETECTION, AND SCREENING METHOD FOR ENGASE ACTIVITY INHIBITOR
-
, (2018/05/03)
PROBLEM TO BE SOLVED: To provide a novel compound that can be used for the detection of endo-β-N-acetylglucosaminidase (ENGase) activity and a screening method useful for the development of ENGase activity inhibitors. SOLUTION: A compound represented by the following formula (I) is useful for the detection of ENGase activity. In the compound, a fluorescent group and an extinction group, which bring about fluorescence resonance energy transfer (FRET), are introduced into a specific pentasaccharide structure. SELECTED DRAWING: None COPYRIGHT: (C)2018,JPOandINPIT